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Abstract
We aimed to assess comprehensively the prevalence of perinatal risks experienced by a
potentially high-risk yet understudied population of children domestically adopted in the
United States. Data are from participant report and medical records from mothers (n = 580)
who completed a domestic adoption placement with nonrelatives at or near birth (Mean
placement age = 7 days). We describe a comprehensive measure of perinatal risks, includ-
ing divergences from previous assessment tools and the incorporation of multiple reporters,
and report the prevalence of various types of perinatal risks. The prevalence of each spe-
cific risk factor was generally low, although several risks were more prevalent in this sample
than estimates from nationally representative publicly available data. Nearly the entire sam-
ple (99%) experienced some type of risk exposure. Birth mothers who placed their children
for adoption domestically in the US experience higher levels of perinatal risks than the
national average, but not for all specific types of risk. Thus, the developmental trajectories
of children adopted domestically may systematically differ from the general population to
the extent that these specific perinatal risks impact development.
Introduction
A large and growing literature suggests that maternal experiences during pregnancy may
impact child development [1–5]. Much of this literature relies on maternal self-report, which
has been shown to be valid when collected appropriately [6]. Medical records and biomarker
data are typically the gold-standards for assessing perinatal risks. In some cases, however, self-
reports collected shortly after pregnancy may yield more complete information about perinatal
experiences than medical record or biomarker data [7]. Maternal report may index a more
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global or pervasive problem potentially missed at specific obstetric visits, or may be more accu-
rate if patients do not feel comfortable being entirely truthful with their obstetric provider (i.e.,
reporting substance use, psychiatric symptoms).
Our goal was to create a comprehensive measure to identify the wide variety of perinatal
conditions that may pose risk to the fetus based on previous assessments [8], including more
current guidelines [9], additional risks shown to affect child outcomes [10, 11], and multiple
reporters. Based on the quality of the data from birth mother self-reports and medical records
from prenatal visits and delivery, we created scores representing the most reliable, valid indica-
tors of the various risks. We then examined the prevalence of the various types of risks in our
putatively high-risk sample of mothers who completed domestic (United States) adoption
plans whereby infants were placed at or near birth to nonrelatives. We report descriptive statis-
tics on the variety and number of risks present and compare the prevalence of our most com-
mon perinatal risks with publically available data from the United States. Thus, this paper is
the first to describe the perinatal risks experienced by this high-risk and under-studied sample
in the literature, provides insights into the types of early life exposures domestically adopted
children in the United States experience, and provides a comparison sample for other studies
adopting a comprehensive approach to examining perinatal risks and child outcomes.
Materials and Methods
Participants and Procedures
Participants were drawn from a sample of 619 birth mothers with medical record and self-
reported data on pregnancy and birth medical and psychiatric complications, recruited as a
part of the Early Growth and Development Study (EGDS). EGDS is a multi-site prospective
longitudinal adoption study tracking birth mothers and fathers, adoptive parents, and adopted
children from birth through late childhood [12]. Mothers were eligible for participation if (1)
the adoption was domestic, (2) the child was placed with a non-relative family (3) prior to 3
months of age (M = 7.11 days postpartum, SD = 13.28), (4) the child had no known major
medical conditions, and (5) the birth mother (and adoptive parents) could read or understand
English at the eighth-grade level. Recruitment occurred between March 2003 and January
2010, through 45 adoption agencies in 15 states. Adoption agencies contacted birth mothers
who provided consent to be contacted by EGDS staff. Staff then called and explained the study
and sent a consent form to birth mothers who were willing to participate. The full sample and
procedures have been described in detail [12]. The research conducted here was approved by
the Institutional Review Boards (IRBs) of all participating organizations (George Washington
University, The Pennsylvania State University, University of California, Davis, University of
Minnesota, Oregon Social Learning Center). Written informed consent was provided by the
participants in this study at each assessment, as approved by the above IRBs. The current study
used data from prenatal care, birth/delivery records, and interviews (usually in their homes) of
birth mothers at ~4 months postpartum, and focuses on the perinatal experiences of the birth
mothers. See Table 1 for sample demographics.
Measures
Self-report. We used two measures to assess perinatal risk via self-report. Interviewers
helped mothers generate a list of life events (i.e., birthdays, holidays) that occurred around the
pregnancy. These events were used to create a Life History Calendar [13, 14] relevant to the
prenatal period (Pregnancy History Calendar) to aid women in recalling prenatal substance
use (alcohol, cigarettes, illicit drugs) and symptoms of depression and anxiety during this time.
Depression and anxiety symptoms were assessed on a scale of 0 (not at all) to 3 (severely) with
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seven items from the Beck Depression Inventory [15] and five items from the Beck Anxiety
Inventory [16]. A subset of each original questionnaire was used to reduce burden on the
mothers.
Mothers also completed a Pregnancy Screening questionnaire that assessed various medical
aspects of the pregnancy, including timing and nature of recognition of pregnancy, weight
changes, blood pressure, vitamin and prescription medication intake, laboratory tests, esti-
mated due date, delivery date, timing and frequency of obstetric visits, and symptoms of ill-
nesses (e.g., flu, sexually transmitted infections, pre-eclampsia).
Medical Records. We developed a coding form and manual (available upon author
request) with close-ended questions assessing a diverse set of maternal and fetal complications,
information on the completeness of prenatal care and birth/delivery records, mothers’ previous
pregnancy outcomes, and other basic information. If the close-ended questions did not cover
all of the information in the record, coders used open-ended questions to record the supple-
mental data exactly as it was presented in the medical records, writing as much as needed.
Reliability was achieved when 2+ coders had attained 100% agreement coding close-ended
questions and 90% agreement coding open-ended questions on the same record. Reliability of
each coder was re-checked every 10 records. If reliability was not met, the coder was instructed
Table 1. Sample Descriptive Statistics.
Mean SD Range
Maternal Age at child birth 24.57 6.17 13.71–45.10
Race/Ethnicity % of sample
Caucasian 70%
Black or African American 13%
Hispanic/Latino 7%
More than one race/ethnicity 5%
Other 5%
Marital Status
Single/Never married/Widowed 43%
Living in committed relationship 32%
Married 13%
Separated 3%
Divorced 9%
Education
Less than high school 20%
High school or equivalent 53%
Beyond high school 27%
Employment
Full-time employment 36%
Part-time employment 15%
Unemployed and looking for work 18%
Full-time homemaker 8%
Other 23%
Mode Range
Modal personal income >$15,000 >$15,000—$70,000–100,000
Modal household income >$15,001 >$15,000—$200,001–300,000
Maternal age is presented in years. Beyond high school includes trade school, 2- and 4- year college
degrees, and graduate study. Further sample details are provided in Leve et al. (2013).
doi:10.1371/journal.pone.0150486.t001
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to code more practice records until reliability was achieved again. In addition to reliability
checks prior to and during data collection, all records were triple coded to ensure all of the data
were collected and recorded accurately. Some records were deemed illegible due to bad hand-
writing or very low copy quality, and were not used (n = 39 records, 6.3%); thus the analysis
sample was 580 birth mothers.
Reporter differences. In cases where the specific risk factor was not present in one type of
report, the other was used exclusively (e.g., we did not ask about diabetes in the self-reported
data, but did code for it in the medical record data; therefore diabetes-related risk must be med-
ical-record report). When medical records and self-report data assessed the same construct but
were discordant, we used what we considered to be the most reliable, valid scores based on the
following decisions:
Regarding the presence/absence of prenatal substance use, we utilized the source in which
use was affirmatively reported, as both self-report and medical record data were expected to be
similarly reliable (reports> 80% concordant across substances). The quantity and frequency of
substance use recorded in medical records was typically vague and inadequate to determine the
degree of intrauterine exposure. In contrast, the quantity and frequency of use of each of 12
addictive substances including alcohol and tobacco was assessed from participants, providing
detail about the degree of use in the self-report data. Therefore, we always used self-reported
data over medical record data for substance use severity which incorporated frequency and
amount of use.
For risks related to pregnancy and birth complications (e.g., prematurity, postmaturity, low
birth weight, perinatal infections, hypertension, pre-eclampsia), medical records data were
preferable as information documented by obstetricians was deemed more accurate than that
recalled by participants. For weight gain and weight loss during pregnancy, we used self-
reported data if the birth mother had not seen an obstetric provider before 12 weeks of gesta-
tion. However, if she had begun prenatal care before 12 weeks, we used medical record report,
as her pre-pregnancy weight would be more likely to be recorded accurately by the health care
provider. For maternal age at birth, we used self-reported data because the maternal age at
birth was calculated based on child and mother birth dates. Finally, for exposures to various
toxins, we used the source that included affirmative report of exposure, as neither reporter was
likely to be much more or less reliable than the other. Because medical records generally
included only the presence or absence of psychiatric conditions, rather than specific symptoms,
or the severity of these symptoms, participant reports of anxiety and depressive symptoms
obtained using validated measures provided more robust indices of internalizing psychopathol-
ogy experienced during pregnancy.
Perinatal Risk Index. We developed a comprehensive coding system for several classes of
pregnancy risk (the Perinatal Risk Index) [17] based primarily on the McNeil-Sjöström obstet-
ric complications scale (M-S) [8, 18]; and other resources (e.g., prenatal care visits [19], expo-
sures to toxins [11]). Each risk factor was assigned a level of risk to the fetus (on a scale of 1–6)
based on McNeil’s general obstetric and pediatric experiences, previous studies of pregnancy
risk factors, and use of consultants [8]. This procedure was followed for all self-reported items
and close-ended items in medical records. The content of the open-ended questions for each
individual was screened by two PhD-level scientists and relevant risks not covered by the close-
ended questions were aggregated and then assigned risk scores according to the M-S scale:
1. = Not harmful or relevant
2. = Not likely harmful or relevant
3. = Potentially but not clearly harmful or relevant
The Perinatal Risk Index
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4. = Potentially clearly harmful or relevant
5. = Potentially clearly greatly harmful/relevant
6. = Very great harm to or deviation in offspring
Quartile scores identifying the rank of anxiety and depressive symptoms (independently) in
the sample were used to index the severity of internalizing symptoms in the sample, in line
with past research (e.g., “high” anxiety has been defined as the top 15% [20] or 25% [21] within
a sample). We assigned the following risk scores in our sample to map onto the M-S scale: bot-
tom 25% of the sample = 1, 25% to 50% = 2, 50%-75% = 3, 75%-85% = 4, and 85%-100% = 5.
Subscales: Eight indexes of pregnancy risk were created: one total score with five subscales,
and two additional scales (described below). Each risk index was comprised of sums subtotals
of items if applicable, and specific items when no subtotals are noted (see online supplement,
S1 Table, for details):
1. Pregnancy Complications: maternal age-related risk (below age 18, 35–40, 40–45,>45
years), inadequate/late prenatal care, multiple gestation, intrauterine growth restriction,
macrosomia, fetal heart rate deviations (e.g., fetal arrhythmia), fetal anemia, vaginal bleed-
ing, placental abnormalities (e.g., single umbilical artery, placental previa), oligohydrami-
nos, polyhydramnios, premature rupture of membranes, weight loss, weight gain outside of
IOM guidelines, nausea, preeclampsia, kidney disease, chronic hypertension, maternal cir-
culatory disorders (e.g., severe hypotension), noninfectious maternal respiratory disorders
(e.g., asthma, bronchitis), maternal hormonal and metabolic disorders (e.g., diabetes, hypo-
glycemia, hypo/hyperthyroid), maternal gastrointestinal tract disorders (e.g., ulcerative coli-
tis, appendicitis, diarrhea, dental infection), neurological conditions (e.g., epilepsy),
maternal infections (e.g., urinary tract infections, upper respiratory infections, pyelonephri-
sis, otitis), maternal sexually transmitted infections (e.g., HIV, gonorrhea, chlamydia), other
maternal trauma (e.g., abortion attempt, abdominal trauma, fractures).
2. Neonatal Complications: deviations in gestational age, birth weight, spina bifida, circulatory
system malformations (e.g., pulmonary stenosis, heart murmur), genital tract malforma-
tions (e.g., hydronephrosis, cryptorchidism), craniosynostosis, fetal alcohol syndrome, con-
genital infections, hyperbilirubinemia, cephalohematoma, early neonatal complications
(e.g., cyanosis, respiratory distress, low Apgar scores), meconium aspiration syndrome,
atrial flutter, bradycardia, blood disorders (e.g., thrombocytopenia, polycythemia), endo-
crinological disorders (e.g., hypocalcemia, hypoglycemia), milia, sepsis, pneumonia, eye
infections, hypothermia, and conditions requiring blood transfusion.
3. Maternal Substance Use: tobacco cigarettes, exposure to secondhand smoke (if not also
smoking), alcohol, marijuana, cocaine, hallucinogens, amphetamines, heroin, prescription
painkillers (used illegally), inhalants, sedatives, and tranquilizers.
4. Exposure to Toxins: exposure to radiation, lead, and chemical toxins.
5. Labor and Delivery: rupture of membranes, induced labor, labor length (prolonged labor or
precipitous delivery), abnormal presentation, cephalopelvic disproportion, operative vaginal
delivery (e.g., forceps or vacuum assisted vaginal delivery), cesarean delivery, intrapartum
fetal heart rate tracing abnormalities (e.g., bradycardia, tachycardia, fetal distress), meco-
nium stained amniotic fluid, umbilical cord complications during delivery (e.g., cord pro-
lapse, cord compression, nuchal or body cord), placental abruption, postpartum
hemorrhage, use of analgesics/anesthetics (e.g., epidural; general, spinal, opiate anesthesia).
The Perinatal Risk Index
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6. Obstetric Complications Summary Score: Pregnancy Complications, Neonatal Complica-
tions, Substance Use, Exposure to Toxins, and Labor and Delivery Complications.
7. Previous Pregnancy Issues: terminations, miscarriages, previous preterm birth
8. Internalizing Symptoms: Anxiety and depression symptoms experienced during pregnancy
Summary scores: Total scores capturing the frequency of experiencing a risk that met the
cutoff of potential risk to the fetus (e.g., a score of 3 or higher) were created to assess the num-
ber of risks present. To capture the severity of risk weighted risk totals [8, 18] are also available
[17]. Here, we report the prevalence of risks using the total scores.
Departures from the McNeil-Sjöström scale: We made several departures from the M-S
scale based on updated literature and current medical guidelines. In addition to the risks
highlighted in the M-S scale, we also included maternal age at child birth as an additional risk
in the pregnancy complications total score [10]. We included exposures to toxins (more toxins
than listed in the original M-S scale) [11] and substance use during pregnancy in separate sum-
mary scores due to conceptual differences in these exposures from other pregnancy complica-
tions, and the growing literatures considering exposures to toxins and substance use during
pregnancy specifically. Weight gain during pregnancy was updated to reflect changes in the
Institute of Medicine guidelines using information on pre-pregnancy body mass index to judge
adequate, inadequate, and excessive weight gain during pregnancy [9]. Finally, we added a pre-
vious pregnancy issues total score.
Results
We present the overall statistics from our summary measures, as well as the most prevalent
risks within each summary measure and a comparison from publicly available data when
possible.
Pregnancy Complications
On average, mothers experienced 2.30 pregnancy complications (at potentially but not clearly
harmful or relevant levels or higher), SD = 1.40, Range = 0–8. Only 48 mothers (8.3%) experi-
enced no pregnancy complications, whereas most mothers (n = 433, ~75.0%) experienced 1–3
distinct risks. Of the pregnancy complications, the top five most prevalent were sexually trans-
mitted infections other than HIV (n = 317), high blood pressure (n = 276), excess weight gain
(n = 77), maternal age-related risk (n = 142), and other infections (n = 123). The prevalence of
high blood pressure in this sample was higher than a national estimate (47.6%, versus ~6–8%
nationally) [22]. The prevalence of excess weight gain was lower than the national prevalence
(24.9%, versus ~50% nationally) [23]. There were fewer very young and more somewhat older
mothers than national estimates (under 19: n = 30, 5% versus ~14% nationally) [24] between
35 and 40: n = 148, 25% versus 10% nationally [25], between 40 and 45, n = 12, 2% versus 2%
nationally [25], older than 45 years of age: n = 1. No comparison data was available for sexually
transmitted infections other than HIV or other infections.
Neonatal Complications
On average, mothers experienced 1.13 neonatal complications, SD = 0.71, Range = 0–7. Most
mothers experienced no (n = 358, 61.7%), or only one neonatal complication (n = 179, 30.9%).
The most prevalent were prematurity (n = 98), low Apgar score at 1, 5, or 10 minutes (n = 75),
hyperbilirubinemia (n = 39), and low birth weight (n = 27). There were slightly more prema-
ture infants in our sample than nationally (16.9%, compared with 12–12.8% nationally) [26].
The Perinatal Risk Index
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There were generally more low Apgar scores (which is associated with lower gestational age)
than reported nationally (12.9%, versus 4% nationally) [27]. We had a similar prevalence of
hyperbilirbinemia as a national estimate (6.7%, versus 3–6% nationally) [28]. Our rate of low
birth weight was slightly lower than national prevalence (4.7%, versus 7.9–8.3% nationally)
[26].
Substance Use
On average, mothers used 1.13 substances, SD = 1.24, Range = 0–6. A large proportion of
mothers did not use any substances (n = 234, 40.0%), although many used one (n = 165,
28.5%), or two or three (n = 153, 26.4%) substances. Cigarette use was the most prevalent
(n = 233), followed by alcohol (n = 92), and marijuana (n = 89). There was some cocaine
(n = 36), amphetamine (n = 51), sedative (n = 39), and prescription painkiller (n = 31) use.
Heroin, hallucinogens, and inhalants were infrequently used (< 3.0% of the sample, com-
bined). There was a higher rate of smoking during pregnancy, marijuana, and cocaine use dur-
ing pregnancy in this sample than reported nationally (cigarettes: 40.0%, versus 20.4%
nationally, marijuana: 15.3%, versus 2.9% nationally; cocaine: 6.2%, versus 1.1% nationally)
[29, 30], but comparable rates of alcohol use (15.9%, versus 18.8% nationally) [29].
Exposure to Toxins
On average, mothers were exposed to 0.38 types of toxins, SD = 0.53, Range = 0–2. The major-
ity of mothers were not exposed to toxins (n = 374, 64.5%), or exposed to only one type
(n = 193, 33.3%). Lead exposure was the most prevalent of the toxins (n = 189, 32.6%, no com-
parison data available).
Labor and Delivery Complications
On average, mothers experienced 1.93 labor/delivery complications, SD = 1.37, Range = 0–7.
Only 97 mothers (16.7%) experienced labor/delivery complications. The majority (n = 408,
70.0%) experienced 1–3 distinct labor/delivery complications. The most prevalent labor/delivery
complications were induction of labor (n = 258), anesthesia (n = 344), cesarean delivery
(n = 138), cord complications (n = 134), and intra-partum fetal heart rate tracing abnormalities
(n = 105). There was more labor induction in this sample compared with that reported nation-
ally (44.5%, versus ~23% nationally) [30]. The use of anesthesia was comparable to that reported
nationally (59.3%, versus 61% nationally) [30]. The prevalence of C-section deliveries was
slightly lower than the national estimates (23.8%, versus 33% nationally) [30]. We had higher
prevalence of cord complications (23.1%, versus ~10% nationally) [31], but lower prevalence of
intra-partum fetal heart rate tracing abnormalities (18.1%, versus ~39% nationally) [32].
Obstetric Complications Total
The obstetric complications total represents the sum of all the specific risks cataloged. In total,
on average mothers experienced 6.31 obstetric complications, SD = 2.43, range = 0–14. This
was a fairly evenly distributed number of risks. Only one mother experienced no complications
of any kind. 23.5% of the sample experienced four or fewer obstetric complications. Only
10.6% of the sample (n = 62) experienced 10 risks or more.
Previous Pregnancy Issues
On average, mothers experienced 0.38 previous pregnancy risks, SD = 0.59, Range = 0–2. The
majority of mothers had no previous pregnancy risks (n = 392, 67.6%), or experienced only
The Perinatal Risk Index
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one (n = 155, 26.7%). These were most often previous terminations (n = 135, 23.3%, no com-
parison data available), with some previous miscarriages (n = 86, 14.8%, versus ~11% nation-
ally) [30].
Internalizing Symptoms
30.2% of the sample was considered to reach risk levels of internalizing symptoms, M = 9.18,
SD = 1.96 (20.0% for depression, M = 4.75, SD = 0.49 symptoms, 20.7% for anxiety, M = 5.84,
SD = 0.37 symptoms). The top 50% of the sample experienced at least one symptom of anxiety
or depression.
Discussion
Virtually all pregnancies in our sample of mothers who placed their children for domestic
adoption in the United States involved some type of perinatal risk, in contrast to previous
reports from other types of samples. For example, in a case-control study, 80% of women with-
out schizophrenia and 89% of schizophrenic participants experienced some risk [18]. More
comprehensive measurement of potential perinatal risk captures more and more diverse expe-
riences. Thus, we may expect this high level of overall risk because we assessed more risks than
typically assessed, or because birth mothers may represent mothers who are at somewhat
higher risk for pregnancy complications than the national average (as noted for some, but not
all of the relatively prevalent specific risks here). This is certainly true for substance use during
pregnancy, as 60% of the sample reported use of at least one substance (e.g., alcohol, cigarettes,
marijuana or other illicit drugs).
Consistent with previous studies [18], the prevalence of most specific risks were low. Of the
more prevalent risks, high blood pressure, maternal age between 35 and 40, prematurity, low
Apgar, labor induction, cord complications, cigarette, marijuana and cocaine use were greater
than national estimates. Thus, it would seem that our sample experienced higher perinatal
risks than the national average, but not for all specific risks. On the whole, the children in this
sample are healthy (see study inclusion criteria), although considered at somewhat higher risk
of developing behavioral and other problems because of genetic and perinatal risk conveyed by
the birth parents [33, 34]. Studies using this sample have found various perinatal risk factors to
be associated with greater variability in hypothalamic-pituitary-adrenal axis functioning, lower
executive functioning, and behavior problems in the children [17, 35–38]. Future studies are
planned to examine specific mechanisms of perinatal risk for child development across
domains, including behavioral and psychiatric symptoms and problems, endocrine develop-
ment, academic achievement, and weight trajectories.
Conclusion
We presented a novel and comprehensive measure of perinatal risk in a sample of mothers
who placed a child for adoption domestically in the United States. More detailed information
on the measure is available upon author request and in online supplements. We have charac-
terized the types of perinatal risks experienced by an under-studied population in the literature.
Using both medical records and self-reported data allowed for a more complete characteriza-
tion of perinatal risks than either alone. However, even the self-report-only version of this mea-
sure has been shown to correlate with a wide variety of child outcomes [17, 35]. Consistent
with other investigations, the prevalence of most specific risks are quite low; however, the accu-
mulation of multiple risk factors is quite common and has important implications for child
development. In the future, we believe this measure will be particularly useful for researchers
investigating the role of the perinatal environment for child development.
The Perinatal Risk Index
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